Floatz logo

18f-flt

Stage IIB Breast Cancer

University of WashingtonSmall moleculePhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
43/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Stage IIB Breast Cancer cohort.

Asset / SponsorPhaseRating
LENVATINIB
University Medical Center Groningen
Phase 4BBB
Decitabine
Virginia Commonwealth University
Phase 2B
FALLYPRIDE
National Cancer Institute (NCI)
Phase 2B
1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-
National Cancer Institute (NCI)
Phase 2B
Tislelizumab
National Cancer Institute (NCI)
Phase 2CCC
Pumvc3-Igfbp2-Her2-Igf1R Plasmid Dna Vaccine
University of Washington
Phase 1CC

Same molecule, other indications

18f-flt is also rated in:

acute lymphoblastic leukemiaDormant
B
Indicative ·
62 / 100
View asset →
breast carcinomaDormant
B
Indicative ·
58 / 100
View asset →
non-small cell lung carcinomaDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →